View recent press releases and browse Hospira's comprehensive release archive.
Since their introduction in Europe, the topic of biosimilars has generated substantial news coverage.
Biosimilars Media Kit
View fact sheets, infographics and policy position papers on biosimilars.
Learn more about how generic injectables are produced and provide affordability.
Learn more about Hospira and our products.
View and search for detailed Hospira product information.
Download Hospira images for editorial use.
Browse highlights from Hospira's rich history.
Media Contact Information
Contact Hospira with a media inquiry.
Accredited members of the media with questions should contact Hospira Public Affairs at (224) 212-2357 (during U.S. business hours) or by email. Only media inquiries will be accepted at this number and email address.
- All other inquiries:
Please contact Hospira.
Hospira is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through our broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 19,000 employees.